India's Venus Remedies gains on marketing nod for chemo drugs

Venus Remedies

16/10/2023 05:48

** Venus Remedies' shares  VENR.NS  rise 4% to 236.55 rupees
    ** CO says got marketing approval for six key chemotherapy
drugs from the Philippines
    ** Adds also got approval to market chemotherapy drug
oxaliplatin from Myanmar 
    ** Over 48,000 shares traded, 2x their 30-day moving avg
    ** Including day's gains, stock has risen ~31% YTD

 (Reporting by Rama Venkat in Bengaluru)
 ((ramavenkat.raman@thomsonreuters.com; https://twitter.com/ramavenkat0607;))